Key facts
- It has raised $1.1B across 4 recorded rounds; the latest was PIPE ($775.0M) in Sep 2021.
- Ginkgo Bioworks has filed 2 Form Ds with the SEC, most recently Sep 2015 ($51.6M sold to 70 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Ginkgo Bioworks
Create free account
No card required
Funding rounds
4 roundsSep 2021PIPE$775.0M▮
May 2020Later Stage VC (Series F)$70.0M▮
Sep 2019Later Stage VC (Series E)$290.0M▮
About Ginkgo Bioworks
- Industry
- Media and Information Services (B2B)
PA Mark — not yet priced
Ginkgo Bioworks doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Ginkgo Bioworks shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Ginkgo Bioworks in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.